These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 36738975

  • 21. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH, Epstein JI.
    Am J Surg Pathol; 2022 Feb 01; 46(2):233-240. PubMed ID: 34619708
    [Abstract] [Full Text] [Related]

  • 22. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.
    Hansum T, Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Osanto S, Pelger RCM, van Wezel T, van der Poel H, Bekers E, Helleman J, Remmers S, van Leenders GJLH.
    Mod Pathol; 2021 Nov 01; 34(11):2064-2070. PubMed ID: 34175896
    [Abstract] [Full Text] [Related]

  • 23. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
    Cai Q, Costa DN, Metter CK, Goldberg K, Roehrborn CG, Cadeddu J, Pedrosa I, Meng X, Mostardeiro TR, Shah RB.
    Urol Oncol; 2022 Oct 01; 40(10):452.e1-452.e8. PubMed ID: 36008255
    [Abstract] [Full Text] [Related]

  • 24. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
    Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, van der Kwast TH, Roobol MJ, van Leenders GJ.
    Mod Pathol; 2016 Jun 01; 29(6):630-6. PubMed ID: 26939875
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY.
    Hum Pathol; 2014 Aug 01; 45(8):1572-81. PubMed ID: 24842280
    [Abstract] [Full Text] [Related]

  • 26. Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
    Khani F, Epstein JI.
    Am J Surg Pathol; 2015 Oct 01; 39(10):1383-9. PubMed ID: 26076065
    [Abstract] [Full Text] [Related]

  • 27. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S.
    J Urol; 2018 Jul 01; 200(1):104-113. PubMed ID: 29408568
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4.
    Chen Z, Pham H, Abreu A, Amin MB, Sherrod AE, Xiao GQ, Aron M.
    Hum Pathol; 2021 Dec 01; 118():18-29. PubMed ID: 34543668
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
    Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA.
    Ann Diagn Pathol; 2021 Jun 01; 52():151725. PubMed ID: 33610958
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens.
    Hollemans E, Verhoef EI, Bangma CH, Schoots I, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH.
    Histopathology; 2019 Sep 01; 75(3):338-345. PubMed ID: 31045262
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set.
    Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N, Maganti M, Van der Kwast T.
    Histopathology; 2019 Feb 01; 74(3):474-482. PubMed ID: 30160779
    [Abstract] [Full Text] [Related]

  • 36. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
    Greenland NY, Cooperberg MR, Carroll PR, Cowan JE, Simko JP, Stohr BA, Chan E.
    Prostate; 2024 Aug 01; 84(11):1076-1085. PubMed ID: 38734990
    [Abstract] [Full Text] [Related]

  • 37. Prognostic parameter for high risk prostate cancer patients at initial presentation.
    Kato M, Kimura K, Hirakawa A, Kobayashi Y, Ishida R, Kamihira O, Majima T, Funahashi Y, Sassa N, Matsukawa Y, Hattori R, Gotoh M, Tsuzuki T.
    Prostate; 2018 Jan 01; 78(1):11-16. PubMed ID: 29094384
    [Abstract] [Full Text] [Related]

  • 38. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH.
    Mod Pathol; 2019 Jan 01; 32(1):139-146. PubMed ID: 30349027
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.